EMD-33045
SARS-CoV-2 spike glycoprotein in complex with neutralizing antibody UT28K
EMD-33045
Single-particle3.1 Å
Deposition: 10/03/2022Map released: 25/05/2022
Last modified: 25/05/2022
Sample Organism:
Severe acute respiratory syndrome coronavirus 2,
Homo sapiens
Sample: SARS-COV-2 spike glycoprotein in complex with UT28K
Deposition Authors: Ozawa T
,
Tani H ,
Anraku Y ,
Kita S ,
Igarashi E,
Saga Y,
Inasaki N,
Kawasuji H,
Yamada H ,
Sasaki S,
Someoka M,
Sasaki J,
Hayakawa Y ,
Yamamoto Y ,
Morinaga Y ,
Kurosawa N ,
Isobe M ,
Fukuhara H ,
Maenaka K,
Hashiguchi T ,
Kishi H ,
Kitajima I ,
Saito S ,
Niimi H
Sample: SARS-COV-2 spike glycoprotein in complex with UT28K
Deposition Authors: Ozawa T
,
Tani H ,
Anraku Y ,
Kita S ,
Igarashi E,
Saga Y,
Inasaki N,
Kawasuji H,
Yamada H ,
Sasaki S,
Someoka M,
Sasaki J,
Hayakawa Y ,
Yamamoto Y ,
Morinaga Y ,
Kurosawa N ,
Isobe M ,
Fukuhara H ,
Maenaka K,
Hashiguchi T ,
Kishi H ,
Kitajima I ,
Saito S ,
Niimi H
Novel super-neutralizing antibody UT28K is capable of protecting against infection from a wide variety of SARS-CoV-2 variants.
Ozawa T ,
Tani H ,
Anraku Y ,
Kita S ,
Igarashi E,
Saga Y,
Inasaki N,
Kawasuji H,
Yamada H ,
Sasaki SI,
Somekawa M ,
Sasaki J,
Hayakawa Y ,
Yamamoto Y ,
Morinaga Y ,
Kurosawa N ,
Isobe M ,
Fukuhara H ,
Maenaka K,
Hashiguchi T ,
Kishi H ,
Kitajima I ,
Saito S ,
Niimi H
(2022) MABs , 14 , 2072455 - 2072455
,
Tani H ,
Anraku Y ,
Kita S ,
Igarashi E,
Saga Y,
Inasaki N,
Kawasuji H,
Yamada H ,
Sasaki SI,
Somekawa M ,
Sasaki J,
Hayakawa Y ,
Yamamoto Y ,
Morinaga Y ,
Kurosawa N ,
Isobe M ,
Fukuhara H ,
Maenaka K,
Hashiguchi T ,
Kishi H ,
Kitajima I ,
Saito S ,
Niimi H
(2022) MABs , 14 , 2072455 - 2072455
Grant Support: